Start-up AFYX Therapeutics believes it has just the ticket for tough-to-treat mucosal diseases with its Rivelin patch technology platform, starting with oral lichen planus, which afflicts some 6m in the US and Europe.
Headquartered in Copenhagen and with a corporate office in San Diego, the company is focusing on developing topical treatments of...








